PharMerica Corp (PMC)

29.10
NYSE : Services
Prev Close 29.10
Day Low/High 0.00 / 0.00
52 Wk Low/High 19.20 / 29.10
Avg Volume 392.50K
Exchange NYSE
Shares Outstanding 31.12M
Market Cap 904.07M
EPS 0.70
P/E Ratio 45.39
Div & Yield N.A. (N.A)

Latest News

PHARMERICA CORPORATION SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes The Acquisition By KKR & Co. L.P. Unit May Be Unfair To Shareholders

PHARMERICA CORPORATION SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes The Acquisition By KKR & Co. L.P. Unit May Be Unfair To Shareholders

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of PharMerica Corporation ("PharMerica") (NYSE: PMC) concerning the...

PharMerica Reaches Analyst Target Price

In recent trading, shares of PharMerica Corp have crossed above the average analyst 12-month target price of $28.00, changing hands for $28.95/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of PharMerica Corporation In Connection With The Sale Of The Company To KR And Walgreens Boots Alliance, Inc.

The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of PharMerica Corporation In Connection With The Sale Of The Company To KR And Walgreens Boots Alliance, Inc.

The Law Offices of Vincent Wong are investigating the Board of Directors of PharMerica Corporation (NYSE:PMC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Concerning Whether The Sale Of PharMerica Corporation To KKR And Walgreens Boots Alliance, Inc. Is Fair To Shareholders

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Concerning Whether The Sale Of PharMerica Corporation To KKR And Walgreens Boots Alliance, Inc. Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased PharMerica Corporation ("PharMerica" or the "Company") (NYSE: PMC) stockĀ  prior to August 2,...

Walgreens Takes Piece of PharMerica, Quest to Dominate Healthcare Continues

Walgreens Takes Piece of PharMerica, Quest to Dominate Healthcare Continues

The deal is worth $1.4 billion and PharMerica's board has already given it the green light.

PharMerica Reports Second Quarter 2017 Results

PharMerica Reports Second Quarter 2017 Results

PharMerica Corporation (NYSE:PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the second quarter ended June 30, 2017.

PharMerica Corporation Enters Into Definitive Agreement To Be Acquired By KKR For $29.25 Per Share In Cash

PharMerica Corporation Enters Into Definitive Agreement To Be Acquired By KKR For $29.25 Per Share In Cash

PharMerica Corporation (NYSE:PMC), a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that it has entered into a definitive merger agreement pursuant...

PharMerica Corporation Announces Second Quarter 2017 Earnings Call And Webcast

PharMerica Corporation Announces Second Quarter 2017 Earnings Call And Webcast

PharMerica Corporation (NYSE:PMC) announced today that it will provide an online webcast of its second quarter 2017 earnings conference call on Friday, August 4, 2017.

Magellan Shares Up Strong After Shelling Out $400M to Buy Senior Whole Health

Magellan Shares Up Strong After Shelling Out $400M to Buy Senior Whole Health

Shares of Magellan surged during mid-morning climbing 4.51% within the first hour.

PMC Makes Notable Cross Below Critical Moving Average

In trading on Wednesday, shares of PharMerica Corp crossed below their 200 day moving average of $24.86, changing hands as low as $24.50 per share. PharMerica Corp shares are currently trading down about 0.9% on the day.

PharMerica Reports First Quarter 2017 Results

PharMerica Corporation (the "Corporation", PharMerica" or the "Company") (NYSE:PMC), a national provider of institutional, specialty home infusion, hospital and specialty pharmacy services, today reported its financial...

13 Things Kentucky Is Best Known for Other Than the Kentucky Derby

13 Things Kentucky Is Best Known for Other Than the Kentucky Derby

All eyes will be on Louisville this weekend, but the Bluegrass State has a wealth of companies and two high-profile politicians.

PharMerica Corporation Announces First Quarter 2017 Earnings Call And Webcast

PharMerica Corporation (NYSE:PMC) announced today that it will provide an online webcast of its first quarter 2017 earnings conference call on Wednesday, May 10, 2017.

PharMerica Announces Date Of 2017 Annual Meeting Of Shareholders

PharMerica Corporation (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today announced that the Company's 2017 annual meeting of shareholders will be held...

PharMerica Acquires CareMed Specialty Pharmacy

PharMerica Corporation (NYSE:PMC), a diversified national provider of institutional and specialty pharmacy services, announced today that it has completed the acquisition of CareMed Specialty Pharmacy ("CareMed").

PharMerica Becomes Oversold (PMC)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

PharMerica Reports Fourth Quarter And Full Year 2016 Results

PharMerica Corporation (the "Corporation" or the "Company") (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the...

PharMerica Corp Breaks Below 200-Day Moving Average - Notable for PMC

In trading on Thursday, shares of PharMerica Corp crossed below their 200 day moving average of $25.50, changing hands as low as $25.39 per share. PharMerica Corp shares are currently trading up about 2.1% on the day.

PharMerica Corporation Announces Fourth Quarter And Year End 2016 Earnings Call And Webcast

PharMerica Corporation (NYSE:PMC) announced today that it will provide an online webcast of its fourth quarter and year end 2016 earnings conference call on Friday, February 24, 2017.

PharMerica Appoints Robert E. Dries As Executive Vice President And Chief Financial Officer

PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced the appointment of Robert E.

PharMerica Breaks Below 200-Day Moving Average - Notable for PMC

PharMerica Breaks Below 200-Day Moving Average - Notable for PMC

In trading on Thursday, shares of PharMerica Corp crossed below their 200 day moving average of $25.27, changing hands as low as $25.10 per share. PharMerica Corp shares are currently trading down about 1.6% on the day.

Analyst Favorites With Strong Buyback Activity: PharMerica Ranks As a Top Pick

Analyst Favorites With Strong Buyback Activity: PharMerica Ranks As a Top Pick

A study of analyst recommendations at the major brokerages shows that PharMerica Corp is the #59 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

PharMerica Announces Expansion Of Existing Credit Facility, Increasing Borrowing Capacity By $150 Million

PharMerica Announces Expansion Of Existing Credit Facility, Increasing Borrowing Capacity By $150 Million

PharMerica Corporation ("PharMerica" or the "Company") (NYSE:PMC), a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that it has successfully...